Louis L.M. van de Ven

Author

Also Known As

L. L. M. Ven, L. L. M. van de Ven, L.L.M. van de Ven, LOUIS L.M. VAN DE VEN, Louis L. M. Van De Ven, Louis L. M. van de Ven, Louis L.M. VAN DE VEN, Louis L.M. Van De Ven, Louis L.M. Van de Ven, Louis L.M. van de Ven

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Erasmus MC Merck (Netherlands)University of Groningen Merck (Germany)

About

Louis L.M. van de Ven is an author at Erasmus University Rotterdam specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	456
2	Emergency Medicine	2	2	324
3	Health Sciences	1	1	46
4	Public Health	1	1	60
5	Biochemistry	1	1	24

Louis L.M. van de Ven

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery Don Poldermans, Eric Boersma, Jeroen J. Bax, New England Journal of Medicine	1999	1.5K
Predictors of Cardiac Events After Major Vascular Surgery Eric Boersma, Don Poldermans, J. J. Bax, JAMA	2001	524
Should Major Vascular Surgery Be Delayed Because of Preoperative Cardiac Testing in Intermediate-Risk Patients Receiving Beta-Blocker Therapy With Tight Heart Rate Control? Don Poldermans, Jeroen J. Bax, Olaf Schouten, Journal of the American College of Cardiology Cardiac SurgeryCardiovascular DiseasePatient SafetyVascular SurgeryOutcomes Research	2006	264
The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery Don Poldermans, Eric Boersma, Jeroen J. Bax, Survey of Anesthesiology Ian R.Cardiac AnaesthesiaSurgeryHero Van UrkAcute Myocardial Infarction	2000	60
Essential fatty acid deficiency: A condition to discriminate prostaglandin and non-prostaglandin mediated components of inflammation I.L. Bonta, Hidde Bult, Louis L.M. van de Ven, Inflammation Research ObesityMetabolic SyndromeInflammationOmega-3 Fatty AcidPhysiology	1976	46
Influence of Order and Type of Drug (Bisoprolol vs. Enalapril) on Outcome and Adverse Events in Patients with Chronic Heart Failure: A <i>post hoc</i> Analysis of the CIBIS-III Trial Christian Funck‐Brentano, Dirk J. van Veldhuisen, Louis L.M. van de Ven, European Journal of Heart Failure	2011	33
Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates Louis L.M. van de Ven, A. Vermeulen, Jan Geert Tans, International Journal of Cardiology Which DrugStable Angina PectorisCardiovascular DiseaseVascular PharmacologyPharmacology	1995	32
Bisoprolol and Hypertension: Effects on Sexual Functioning in Men C. P. Matthijs Broekman, Stefan M. Haensel, Louis L.M. van de Ven, Journal of Sex & Marital Therapy	1992	30
Increased Plasma Concentration of Natriuretic Peptides by Selective β1-Blocker Bisoprolol Anton H. van den Meiracker, Thomas W. Lameris, Louis L.M. van de Ven, Journal of Cardiovascular Pharmacology HypertensionNp Clearance ReceptorCardiovascular PharmacologyPeptide SciencePharmacotherapy	2003	24
Comparison of the Safety and Efficacy of Bisoprolol Versus Atenolol in Stable Exercise-Induced Angina Pectoris: A Multicenter International Randomized Study of Angina Pectoris (MIRSA) Ebo D. de Muinck, Dorit Buchner-Moell, Louis L.M. van de Ven, Journal of Cardiovascular Pharmacology	1992	20

Page 1